Is CYP2C19 useful for weight loss?

CYP2C19 is a drug-metabolizing enzyme, primarily relevant for medications like clopidogrel and proton pump inhibitors. There is no robust scientific evidence that CYP2C19 variants directly affect weight loss. Some indirect links (e.g., via metabolism of antidepressants that influence weight) are speculative and not clinically validated. Consumer DNA tests claiming CYP2C19 is useful for weight management overstate the evidence. The main clinical utility is pharmacogenetic (CPIC Level A for certain drugs). For weight loss, lifestyle, calorie balance, and physical activity remain the key drivers – not this gene.